Biofrontera Inc. Shareholders' Equity
Biofrontera Inc. (BFRI) had Shareholders' Equity of $5.96 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $5.96M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $6.07M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $10.48M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$2.58M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $5.96M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $6.07M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $10.48M 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$2.58M 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$4.67M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $469.00K 10-Q · filed 2026-08-13 |
| 2024-12-31 | $4.43M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $5.53M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $10.91M 10-Q · filed 2025-11-12 |
| 2024-03-31 | -$5.42M 10-Q · filed 2025-08-13 |
| 2023-12-31 | $4.79M 10-K · filed 2026-03-19 |
| 2023-09-30 | $1.04M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $7.17M 10-Q · filed 2024-11-14 |
| 2023-03-31 | $16.75M 10-Q · filed 2024-08-14 |
| 2022-12-31 | $23.88M 10-K · filed 2025-03-20 |
| 2022-09-30 | $22.59M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $17.23M 10-Q · filed 2023-11-09 |
| 2022-03-31 | $17.42M 10-Q · filed 2023-08-11 |
| 2021-12-31 | $11.34M 10-K · filed 2024-03-15 |
| 2021-09-30 | -$17.38M 10-Q · filed 2022-11-14 |
| 2021-06-30 | -$1.37M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $2.29M 10-Q · filed 2022-08-12 |
| 2020-12-31 | $5.83M 8-K · filed 2023-10-03 |
| 2020-09-30 | -$40.98M 10-Q · filed 2021-11-30 |
| 2020-06-30 | -$37.99M 10-Q · filed 2021-11-30 |
| 2019-12-31 | -$30.18M 10-K · filed 2022-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |